Global Parkinson Disease Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Parkinson Disease Drug market size was valued at USD 5651 million in 2023 and is forecast to a readjusted size of USD 8439.2 million by 2030 with a CAGR of 5.9% during review period.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
The Global Info Research report includes an overview of the development of the Parkinson Disease Drug industry chain, the market status of Under 40 Years Old (Sinemet-CR, Trastal), 40-65 Years Old (Sinemet-CR, Trastal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson Disease Drug.
Regionally, the report analyzes the Parkinson Disease Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson Disease Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson Disease Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson Disease Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sinemet-CR, Trastal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson Disease Drug market.
Regional Analysis: The report involves examining the Parkinson Disease Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson Disease Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson Disease Drug:
Company Analysis: Report covers individual Parkinson Disease Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson Disease Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Under 40 Years Old, 40-65 Years Old).
Technology Analysis: Report covers specific technologies relevant to Parkinson Disease Drug. It assesses the current state, advancements, and potential future developments in Parkinson Disease Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson Disease Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Parkinson Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson Disease Drug, with revenue, gross margin and global market share of Parkinson Disease Drug from 2019 to 2024.
Chapter 3, the Parkinson Disease Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson Disease Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson Disease Drug.
Chapter 13, to describe Parkinson Disease Drug research findings and conclusion.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
The Global Info Research report includes an overview of the development of the Parkinson Disease Drug industry chain, the market status of Under 40 Years Old (Sinemet-CR, Trastal), 40-65 Years Old (Sinemet-CR, Trastal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson Disease Drug.
Regionally, the report analyzes the Parkinson Disease Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson Disease Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson Disease Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson Disease Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sinemet-CR, Trastal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson Disease Drug market.
Regional Analysis: The report involves examining the Parkinson Disease Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson Disease Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson Disease Drug:
Company Analysis: Report covers individual Parkinson Disease Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson Disease Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Under 40 Years Old, 40-65 Years Old).
Technology Analysis: Report covers specific technologies relevant to Parkinson Disease Drug. It assesses the current state, advancements, and potential future developments in Parkinson Disease Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson Disease Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Other
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Bausch Health
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Parkinson Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson Disease Drug, with revenue, gross margin and global market share of Parkinson Disease Drug from 2019 to 2024.
Chapter 3, the Parkinson Disease Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson Disease Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson Disease Drug.
Chapter 13, to describe Parkinson Disease Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Parkinson Disease Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson Disease Drug by Type
1.3.1 Overview: Global Parkinson Disease Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson Disease Drug Consumption Value Market Share by Type in 2023
1.3.3 Sinemet-CR
1.3.4 Trastal
1.3.5 Madopar
1.3.6 COMT Inhibitor
1.3.7 Other
1.4 Global Parkinson Disease Drug Market by Application
1.4.1 Overview: Global Parkinson Disease Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Under 40 Years Old
1.4.3 40-65 Years Old
1.4.4 Above 65 Years Old
1.5 Global Parkinson Disease Drug Market Size & Forecast
1.6 Global Parkinson Disease Drug Market Size and Forecast by Region
1.6.1 Global Parkinson Disease Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson Disease Drug Market Size by Region, (2019-2030)
1.6.3 North America Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson Disease Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Parkinson Disease Drug Product and Solutions
2.1.4 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments and Future Plans
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Parkinson Disease Drug Product and Solutions
2.2.4 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Akorn Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinson Disease Drug Product and Solutions
2.3.4 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Parkinson Disease Drug Product and Solutions
2.4.4 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
2.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson Disease Drug Product and Solutions
2.7.4 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Kyowa Hakko Kirin Pharma
2.8.1 Kyowa Hakko Kirin Pharma Details
2.8.2 Kyowa Hakko Kirin Pharma Major Business
2.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
2.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business
2.9.3 Astellas Pharma Parkinson Disease Drug Product and Solutions
2.9.4 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Astellas Pharma Recent Developments and Future Plans
2.10 Desitin Arzneimittel
2.10.1 Desitin Arzneimittel Details
2.10.2 Desitin Arzneimittel Major Business
2.10.3 Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
2.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Desitin Arzneimittel Recent Developments and Future Plans
2.11 Endo Pharmaceuticals
2.11.1 Endo Pharmaceuticals Details
2.11.2 Endo Pharmaceuticals Major Business
2.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
2.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.12 F.Hoffmann-La Roche
2.12.1 F.Hoffmann-La Roche Details
2.12.2 F.Hoffmann-La Roche Major Business
2.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
2.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 F.Hoffmann-La Roche Recent Developments and Future Plans
2.13 H.Lundbeck
2.13.1 H.Lundbeck Details
2.13.2 H.Lundbeck Major Business
2.13.3 H.Lundbeck Parkinson Disease Drug Product and Solutions
2.13.4 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 H.Lundbeck Recent Developments and Future Plans
2.14 Valeant
2.14.1 Valeant Details
2.14.2 Valeant Major Business
2.14.3 Valeant Parkinson Disease Drug Product and Solutions
2.14.4 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Valeant Recent Developments and Future Plans
2.15 Apokyn
2.15.1 Apokyn Details
2.15.2 Apokyn Major Business
2.15.3 Apokyn Parkinson Disease Drug Product and Solutions
2.15.4 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Apokyn Recent Developments and Future Plans
2.16 Orion
2.16.1 Orion Details
2.16.2 Orion Major Business
2.16.3 Orion Parkinson Disease Drug Product and Solutions
2.16.4 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Orion Recent Developments and Future Plans
2.17 Stada Arzneimittel
2.17.1 Stada Arzneimittel Details
2.17.2 Stada Arzneimittel Major Business
2.17.3 Stada Arzneimittel Parkinson Disease Drug Product and Solutions
2.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Stada Arzneimittel Recent Developments and Future Plans
2.18 US WorldMeds
2.18.1 US WorldMeds Details
2.18.2 US WorldMeds Major Business
2.18.3 US WorldMeds Parkinson Disease Drug Product and Solutions
2.18.4 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 US WorldMeds Recent Developments and Future Plans
2.19 Bausch Health
2.19.1 Bausch Health Details
2.19.2 Bausch Health Major Business
2.19.3 Bausch Health Parkinson Disease Drug Product and Solutions
2.19.4 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Bausch Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson Disease Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson Disease Drug by Company Revenue
3.2.2 Top 3 Parkinson Disease Drug Players Market Share in 2023
3.2.3 Top 6 Parkinson Disease Drug Players Market Share in 2023
3.3 Parkinson Disease Drug Market: Overall Company Footprint Analysis
3.3.1 Parkinson Disease Drug Market: Region Footprint
3.3.2 Parkinson Disease Drug Market: Company Product Type Footprint
3.3.3 Parkinson Disease Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson Disease Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson Disease Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson Disease Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson Disease Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson Disease Drug Consumption Value by Type (2019-2030)
6.2 North America Parkinson Disease Drug Consumption Value by Application (2019-2030)
6.3 North America Parkinson Disease Drug Market Size by Country
6.3.1 North America Parkinson Disease Drug Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson Disease Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson Disease Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson Disease Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson Disease Drug Consumption Value by Type (2019-2030)
7.2 Europe Parkinson Disease Drug Consumption Value by Application (2019-2030)
7.3 Europe Parkinson Disease Drug Market Size by Country
7.3.1 Europe Parkinson Disease Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.3 France Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson Disease Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.3.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2019-2030)
8.3.2 China Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.5 India Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson Disease Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson Disease Drug Consumption Value by Type (2019-2030)
9.2 South America Parkinson Disease Drug Consumption Value by Application (2019-2030)
9.3 South America Parkinson Disease Drug Market Size by Country
9.3.1 South America Parkinson Disease Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson Disease Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson Disease Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.3.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson Disease Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson Disease Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson Disease Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson Disease Drug Market Drivers
11.2 Parkinson Disease Drug Market Restraints
11.3 Parkinson Disease Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson Disease Drug Industry Chain
12.2 Parkinson Disease Drug Upstream Analysis
12.3 Parkinson Disease Drug Midstream Analysis
12.4 Parkinson Disease Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Parkinson Disease Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson Disease Drug by Type
1.3.1 Overview: Global Parkinson Disease Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson Disease Drug Consumption Value Market Share by Type in 2023
1.3.3 Sinemet-CR
1.3.4 Trastal
1.3.5 Madopar
1.3.6 COMT Inhibitor
1.3.7 Other
1.4 Global Parkinson Disease Drug Market by Application
1.4.1 Overview: Global Parkinson Disease Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Under 40 Years Old
1.4.3 40-65 Years Old
1.4.4 Above 65 Years Old
1.5 Global Parkinson Disease Drug Market Size & Forecast
1.6 Global Parkinson Disease Drug Market Size and Forecast by Region
1.6.1 Global Parkinson Disease Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson Disease Drug Market Size by Region, (2019-2030)
1.6.3 North America Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson Disease Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson Disease Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Parkinson Disease Drug Product and Solutions
2.1.4 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments and Future Plans
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Parkinson Disease Drug Product and Solutions
2.2.4 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Akorn Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinson Disease Drug Product and Solutions
2.3.4 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Parkinson Disease Drug Product and Solutions
2.4.4 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
2.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson Disease Drug Product and Solutions
2.7.4 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Kyowa Hakko Kirin Pharma
2.8.1 Kyowa Hakko Kirin Pharma Details
2.8.2 Kyowa Hakko Kirin Pharma Major Business
2.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
2.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business
2.9.3 Astellas Pharma Parkinson Disease Drug Product and Solutions
2.9.4 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Astellas Pharma Recent Developments and Future Plans
2.10 Desitin Arzneimittel
2.10.1 Desitin Arzneimittel Details
2.10.2 Desitin Arzneimittel Major Business
2.10.3 Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
2.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Desitin Arzneimittel Recent Developments and Future Plans
2.11 Endo Pharmaceuticals
2.11.1 Endo Pharmaceuticals Details
2.11.2 Endo Pharmaceuticals Major Business
2.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
2.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.12 F.Hoffmann-La Roche
2.12.1 F.Hoffmann-La Roche Details
2.12.2 F.Hoffmann-La Roche Major Business
2.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
2.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 F.Hoffmann-La Roche Recent Developments and Future Plans
2.13 H.Lundbeck
2.13.1 H.Lundbeck Details
2.13.2 H.Lundbeck Major Business
2.13.3 H.Lundbeck Parkinson Disease Drug Product and Solutions
2.13.4 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 H.Lundbeck Recent Developments and Future Plans
2.14 Valeant
2.14.1 Valeant Details
2.14.2 Valeant Major Business
2.14.3 Valeant Parkinson Disease Drug Product and Solutions
2.14.4 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Valeant Recent Developments and Future Plans
2.15 Apokyn
2.15.1 Apokyn Details
2.15.2 Apokyn Major Business
2.15.3 Apokyn Parkinson Disease Drug Product and Solutions
2.15.4 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Apokyn Recent Developments and Future Plans
2.16 Orion
2.16.1 Orion Details
2.16.2 Orion Major Business
2.16.3 Orion Parkinson Disease Drug Product and Solutions
2.16.4 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Orion Recent Developments and Future Plans
2.17 Stada Arzneimittel
2.17.1 Stada Arzneimittel Details
2.17.2 Stada Arzneimittel Major Business
2.17.3 Stada Arzneimittel Parkinson Disease Drug Product and Solutions
2.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Stada Arzneimittel Recent Developments and Future Plans
2.18 US WorldMeds
2.18.1 US WorldMeds Details
2.18.2 US WorldMeds Major Business
2.18.3 US WorldMeds Parkinson Disease Drug Product and Solutions
2.18.4 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 US WorldMeds Recent Developments and Future Plans
2.19 Bausch Health
2.19.1 Bausch Health Details
2.19.2 Bausch Health Major Business
2.19.3 Bausch Health Parkinson Disease Drug Product and Solutions
2.19.4 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Bausch Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson Disease Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson Disease Drug by Company Revenue
3.2.2 Top 3 Parkinson Disease Drug Players Market Share in 2023
3.2.3 Top 6 Parkinson Disease Drug Players Market Share in 2023
3.3 Parkinson Disease Drug Market: Overall Company Footprint Analysis
3.3.1 Parkinson Disease Drug Market: Region Footprint
3.3.2 Parkinson Disease Drug Market: Company Product Type Footprint
3.3.3 Parkinson Disease Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson Disease Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson Disease Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson Disease Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson Disease Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson Disease Drug Consumption Value by Type (2019-2030)
6.2 North America Parkinson Disease Drug Consumption Value by Application (2019-2030)
6.3 North America Parkinson Disease Drug Market Size by Country
6.3.1 North America Parkinson Disease Drug Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson Disease Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson Disease Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson Disease Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson Disease Drug Consumption Value by Type (2019-2030)
7.2 Europe Parkinson Disease Drug Consumption Value by Application (2019-2030)
7.3 Europe Parkinson Disease Drug Market Size by Country
7.3.1 Europe Parkinson Disease Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.3 France Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson Disease Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson Disease Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.3.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2019-2030)
8.3.2 China Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.5 India Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson Disease Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson Disease Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson Disease Drug Consumption Value by Type (2019-2030)
9.2 South America Parkinson Disease Drug Consumption Value by Application (2019-2030)
9.3 South America Parkinson Disease Drug Market Size by Country
9.3.1 South America Parkinson Disease Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson Disease Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson Disease Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.3.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson Disease Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson Disease Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson Disease Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson Disease Drug Market Drivers
11.2 Parkinson Disease Drug Market Restraints
11.3 Parkinson Disease Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson Disease Drug Industry Chain
12.2 Parkinson Disease Drug Upstream Analysis
12.3 Parkinson Disease Drug Midstream Analysis
12.4 Parkinson Disease Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck Company Information, Head Office, and Major Competitors
Table 6. Merck Major Business
Table 7. Merck Parkinson Disease Drug Product and Solutions
Table 8. Merck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck Recent Developments and Future Plans
Table 10. Akorn Company Information, Head Office, and Major Competitors
Table 11. Akorn Major Business
Table 12. Akorn Parkinson Disease Drug Product and Solutions
Table 13. Akorn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Akorn Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Parkinson Disease Drug Product and Solutions
Table 18. GSK Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Parkinson Disease Drug Product and Solutions
Table 23. Novartis Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
Table 28. Boehringer Ingelheim Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Major Business
Table 32. Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
Table 33. Teva Pharmaceutical Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Teva Pharmaceutical Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Parkinson Disease Drug Product and Solutions
Table 38. Abbvie Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Kyowa Hakko Kirin Pharma Company Information, Head Office, and Major Competitors
Table 41. Kyowa Hakko Kirin Pharma Major Business
Table 42. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
Table 43. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
Table 45. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 46. Astellas Pharma Major Business
Table 47. Astellas Pharma Parkinson Disease Drug Product and Solutions
Table 48. Astellas Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Astellas Pharma Recent Developments and Future Plans
Table 50. Desitin Arzneimittel Company Information, Head Office, and Major Competitors
Table 51. Desitin Arzneimittel Major Business
Table 52. Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
Table 53. Desitin Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Desitin Arzneimittel Recent Developments and Future Plans
Table 55. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 56. Endo Pharmaceuticals Major Business
Table 57. Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
Table 58. Endo Pharmaceuticals Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Endo Pharmaceuticals Recent Developments and Future Plans
Table 60. F.Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 61. F.Hoffmann-La Roche Major Business
Table 62. F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
Table 63. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. F.Hoffmann-La Roche Recent Developments and Future Plans
Table 65. H.Lundbeck Company Information, Head Office, and Major Competitors
Table 66. H.Lundbeck Major Business
Table 67. H.Lundbeck Parkinson Disease Drug Product and Solutions
Table 68. H.Lundbeck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. H.Lundbeck Recent Developments and Future Plans
Table 70. Valeant Company Information, Head Office, and Major Competitors
Table 71. Valeant Major Business
Table 72. Valeant Parkinson Disease Drug Product and Solutions
Table 73. Valeant Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Valeant Recent Developments and Future Plans
Table 75. Apokyn Company Information, Head Office, and Major Competitors
Table 76. Apokyn Major Business
Table 77. Apokyn Parkinson Disease Drug Product and Solutions
Table 78. Apokyn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Apokyn Recent Developments and Future Plans
Table 80. Orion Company Information, Head Office, and Major Competitors
Table 81. Orion Major Business
Table 82. Orion Parkinson Disease Drug Product and Solutions
Table 83. Orion Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Orion Recent Developments and Future Plans
Table 85. Stada Arzneimittel Company Information, Head Office, and Major Competitors
Table 86. Stada Arzneimittel Major Business
Table 87. Stada Arzneimittel Parkinson Disease Drug Product and Solutions
Table 88. Stada Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Stada Arzneimittel Recent Developments and Future Plans
Table 90. US WorldMeds Company Information, Head Office, and Major Competitors
Table 91. US WorldMeds Major Business
Table 92. US WorldMeds Parkinson Disease Drug Product and Solutions
Table 93. US WorldMeds Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. US WorldMeds Recent Developments and Future Plans
Table 95. Bausch Health Company Information, Head Office, and Major Competitors
Table 96. Bausch Health Major Business
Table 97. Bausch Health Parkinson Disease Drug Product and Solutions
Table 98. Bausch Health Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Bausch Health Recent Developments and Future Plans
Table 100. Global Parkinson Disease Drug Revenue (USD Million) by Players (2019-2024)
Table 101. Global Parkinson Disease Drug Revenue Share by Players (2019-2024)
Table 102. Breakdown of Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Parkinson Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Parkinson Disease Drug Players
Table 105. Parkinson Disease Drug Market: Company Product Type Footprint
Table 106. Parkinson Disease Drug Market: Company Product Application Footprint
Table 107. Parkinson Disease Drug New Market Entrants and Barriers to Market Entry
Table 108. Parkinson Disease Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Parkinson Disease Drug Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Parkinson Disease Drug Consumption Value Share by Type (2019-2024)
Table 111. Global Parkinson Disease Drug Consumption Value Forecast by Type (2025-2030)
Table 112. Global Parkinson Disease Drug Consumption Value by Application (2019-2024)
Table 113. Global Parkinson Disease Drug Consumption Value Forecast by Application (2025-2030)
Table 114. North America Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Parkinson Disease Drug Raw Material
Table 145. Key Suppliers of Parkinson Disease Drug Raw Materials
Table 1. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck Company Information, Head Office, and Major Competitors
Table 6. Merck Major Business
Table 7. Merck Parkinson Disease Drug Product and Solutions
Table 8. Merck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck Recent Developments and Future Plans
Table 10. Akorn Company Information, Head Office, and Major Competitors
Table 11. Akorn Major Business
Table 12. Akorn Parkinson Disease Drug Product and Solutions
Table 13. Akorn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Akorn Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Parkinson Disease Drug Product and Solutions
Table 18. GSK Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Parkinson Disease Drug Product and Solutions
Table 23. Novartis Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
Table 28. Boehringer Ingelheim Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Major Business
Table 32. Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
Table 33. Teva Pharmaceutical Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Teva Pharmaceutical Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Parkinson Disease Drug Product and Solutions
Table 38. Abbvie Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Kyowa Hakko Kirin Pharma Company Information, Head Office, and Major Competitors
Table 41. Kyowa Hakko Kirin Pharma Major Business
Table 42. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
Table 43. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
Table 45. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 46. Astellas Pharma Major Business
Table 47. Astellas Pharma Parkinson Disease Drug Product and Solutions
Table 48. Astellas Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Astellas Pharma Recent Developments and Future Plans
Table 50. Desitin Arzneimittel Company Information, Head Office, and Major Competitors
Table 51. Desitin Arzneimittel Major Business
Table 52. Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
Table 53. Desitin Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Desitin Arzneimittel Recent Developments and Future Plans
Table 55. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 56. Endo Pharmaceuticals Major Business
Table 57. Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
Table 58. Endo Pharmaceuticals Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Endo Pharmaceuticals Recent Developments and Future Plans
Table 60. F.Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 61. F.Hoffmann-La Roche Major Business
Table 62. F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
Table 63. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. F.Hoffmann-La Roche Recent Developments and Future Plans
Table 65. H.Lundbeck Company Information, Head Office, and Major Competitors
Table 66. H.Lundbeck Major Business
Table 67. H.Lundbeck Parkinson Disease Drug Product and Solutions
Table 68. H.Lundbeck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. H.Lundbeck Recent Developments and Future Plans
Table 70. Valeant Company Information, Head Office, and Major Competitors
Table 71. Valeant Major Business
Table 72. Valeant Parkinson Disease Drug Product and Solutions
Table 73. Valeant Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Valeant Recent Developments and Future Plans
Table 75. Apokyn Company Information, Head Office, and Major Competitors
Table 76. Apokyn Major Business
Table 77. Apokyn Parkinson Disease Drug Product and Solutions
Table 78. Apokyn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Apokyn Recent Developments and Future Plans
Table 80. Orion Company Information, Head Office, and Major Competitors
Table 81. Orion Major Business
Table 82. Orion Parkinson Disease Drug Product and Solutions
Table 83. Orion Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Orion Recent Developments and Future Plans
Table 85. Stada Arzneimittel Company Information, Head Office, and Major Competitors
Table 86. Stada Arzneimittel Major Business
Table 87. Stada Arzneimittel Parkinson Disease Drug Product and Solutions
Table 88. Stada Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Stada Arzneimittel Recent Developments and Future Plans
Table 90. US WorldMeds Company Information, Head Office, and Major Competitors
Table 91. US WorldMeds Major Business
Table 92. US WorldMeds Parkinson Disease Drug Product and Solutions
Table 93. US WorldMeds Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. US WorldMeds Recent Developments and Future Plans
Table 95. Bausch Health Company Information, Head Office, and Major Competitors
Table 96. Bausch Health Major Business
Table 97. Bausch Health Parkinson Disease Drug Product and Solutions
Table 98. Bausch Health Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Bausch Health Recent Developments and Future Plans
Table 100. Global Parkinson Disease Drug Revenue (USD Million) by Players (2019-2024)
Table 101. Global Parkinson Disease Drug Revenue Share by Players (2019-2024)
Table 102. Breakdown of Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Parkinson Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Parkinson Disease Drug Players
Table 105. Parkinson Disease Drug Market: Company Product Type Footprint
Table 106. Parkinson Disease Drug Market: Company Product Application Footprint
Table 107. Parkinson Disease Drug New Market Entrants and Barriers to Market Entry
Table 108. Parkinson Disease Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Parkinson Disease Drug Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Parkinson Disease Drug Consumption Value Share by Type (2019-2024)
Table 111. Global Parkinson Disease Drug Consumption Value Forecast by Type (2025-2030)
Table 112. Global Parkinson Disease Drug Consumption Value by Application (2019-2024)
Table 113. Global Parkinson Disease Drug Consumption Value Forecast by Application (2025-2030)
Table 114. North America Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Parkinson Disease Drug Raw Material
Table 145. Key Suppliers of Parkinson Disease Drug Raw Materials
LIST OF FIGURES
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson Disease Drug Consumption Value Market Share by Type in 2023
Figure 4. Sinemet-CR
Figure 5. Trastal
Figure 6. Madopar
Figure 7. COMT Inhibitor
Figure 8. Other
Figure 9. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Parkinson Disease Drug Consumption Value Market Share by Application in 2023
Figure 11. Under 40 Years Old Picture
Figure 12. 40-65 Years Old Picture
Figure 13. Above 65 Years Old Picture
Figure 14. Global Parkinson Disease Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Parkinson Disease Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Parkinson Disease Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Parkinson Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Parkinson Disease Drug Consumption Value Market Share by Region in 2023
Figure 19. North America Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Parkinson Disease Drug Revenue Share by Players in 2023
Figure 25. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Parkinson Disease Drug Market Share in 2023
Figure 27. Global Top 6 Players Parkinson Disease Drug Market Share in 2023
Figure 28. Global Parkinson Disease Drug Consumption Value Share by Type (2019-2024)
Figure 29. Global Parkinson Disease Drug Market Share Forecast by Type (2025-2030)
Figure 30. Global Parkinson Disease Drug Consumption Value Share by Application (2019-2024)
Figure 31. Global Parkinson Disease Drug Market Share Forecast by Application (2025-2030)
Figure 32. North America Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. France Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 49. China Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. India Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 66. Parkinson Disease Drug Market Drivers
Figure 67. Parkinson Disease Drug Market Restraints
Figure 68. Parkinson Disease Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Parkinson Disease Drug in 2023
Figure 71. Manufacturing Process Analysis of Parkinson Disease Drug
Figure 72. Parkinson Disease Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson Disease Drug Consumption Value Market Share by Type in 2023
Figure 4. Sinemet-CR
Figure 5. Trastal
Figure 6. Madopar
Figure 7. COMT Inhibitor
Figure 8. Other
Figure 9. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Parkinson Disease Drug Consumption Value Market Share by Application in 2023
Figure 11. Under 40 Years Old Picture
Figure 12. 40-65 Years Old Picture
Figure 13. Above 65 Years Old Picture
Figure 14. Global Parkinson Disease Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Parkinson Disease Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Parkinson Disease Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Parkinson Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Parkinson Disease Drug Consumption Value Market Share by Region in 2023
Figure 19. North America Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Parkinson Disease Drug Revenue Share by Players in 2023
Figure 25. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Parkinson Disease Drug Market Share in 2023
Figure 27. Global Top 6 Players Parkinson Disease Drug Market Share in 2023
Figure 28. Global Parkinson Disease Drug Consumption Value Share by Type (2019-2024)
Figure 29. Global Parkinson Disease Drug Market Share Forecast by Type (2025-2030)
Figure 30. Global Parkinson Disease Drug Consumption Value Share by Application (2019-2024)
Figure 31. Global Parkinson Disease Drug Market Share Forecast by Application (2025-2030)
Figure 32. North America Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. France Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Region (2019-2030)
Figure 49. China Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. India Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Parkinson Disease Drug Consumption Value (2019-2030) & (USD Million)
Figure 66. Parkinson Disease Drug Market Drivers
Figure 67. Parkinson Disease Drug Market Restraints
Figure 68. Parkinson Disease Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Parkinson Disease Drug in 2023
Figure 71. Manufacturing Process Analysis of Parkinson Disease Drug
Figure 72. Parkinson Disease Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
